Rani Therapeutics Holdings, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Talat Imran, with a market cap of $94.0M.
Based on Q1 2026 filing
Common questions about Rani Therapeutics Holdings, Inc.
Rani Therapeutics Holdings, Inc. (RANI) has a market capitalization of $94.0M and trades on NASDAQ.
Rani Therapeutics Holdings, Inc. has approximately 140 employees.